ACLX · As filed with the SEC

Arcellx income statement, by quarter

The statement as Arcellx presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS · USD, except per-share amounts

USD, except per-share amountsQ4 2025
3 months ended Dec 31, 2025
Q3 2025
3 months ended Sep 30, 2025
Q2 2025
3 months ended Jun 30, 2025
Q1 2025
3 months ended Mar 31, 2025
Q4 2024
3 months ended Dec 31, 2024
Collaboration revenue from related party—4,949,0007,554,0008,129,000—
Operating expenses:
Research and development—35,088,00037,627,00050,801,000—
General and administrative—31,637,00028,653,00026,226,000—
Total operating expenses—66,725,00066,280,00077,027,000—
Loss from operations—(61,776,000)(58,726,000)(68,898,000)—
Other income (expense):
Interest and other income (expense)—5,995,0005,984,0006,640,000—
Interest expense—00(12,000)—
Total other income, net—5,995,0005,984,0006,628,000—
Loss before income taxes—(55,781,000)(52,742,000)(62,270,000)—
Income tax expense—0(29,000)0—
Net loss—(55,781,000)(52,771,000)(62,270,000)—
Other comprehensive loss:
Unrealized gain (loss) on marketable securities—303,000(246,000)(199,000)—
Comprehensive loss—(55,478,000)(53,017,000)(62,469,000)—
Net loss per share attributable to common stockholders - basic—(0.99)(0.94)(1.13)—
Net loss per share attributable to common stockholders - diluted—(0.99)(0.94)(1.13)—
Weighted-average common shares outstanding - basic—56,587,16756,221,33155,256,464—
Weighted-average common shares outstanding - diluted—56,587,16756,221,33155,256,464—

As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.